bioRxivEvolutionary Biology
Evolution of bacterial persistence to antibiotics during a 50,000-generation experiment in an antibiotic-free environment
Abstract
Failure of antibiotic therapies causes > 700,000 deaths yearly and involves both bacterial resistance and persistence. Persistence results in the relapse of infections by producing a tiny fraction of pathogen survivors that stay dormant during antibiotic exposure. From an evolutionary perspective, persistence is either a bet-hedging strategy that helps to cope with stochastically changing environments or an unavoidable minimal rate of cellular errors that lock the cells in a low activity state. Here, we analyzed the evolution of persistence over 50,000 bacterial generations in a stable environment by improving a published method that estimates the number of persister cells based on the growth of the reviving population. Our results challenged our understanding of the factors underlying persistence evolution. In one case, we observed a substantial decrease in persistence proportion, suggesting that the naturally observed persistence level is not an unavoidable minimal rate of cellular errors. However, although there was no obvious environmental stochasticity, in 11 of the 12 investigated populations, the persistence level was maintained during 50,000 bacterial generations.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Observation of persister cell histories reveals diverse modes of survival in antibiotic persistence
M. Umetani, M. Fujisawa, … Y. Wakamoto·bioRxiv·Oct 28, 2021
- The power of dying slowly - persistence as unintentional dormancy
J. S. Rebelo, C. P. F. Domingues, … F. Dionisio·bioRxiv·Jan 20, 2021
- A link between aging and persistence
Audrey Menegaz Proenca, Camilla Ulla Rang, Lin Chao·Antimicrobial Agents and ChemotherapyPeer-reviewed·Feb 21, 2025
- Bacterial persistence emerges mainly from antibiotic-specific networks rather than slow growth
François Beaufay, Camille Froment, … Laurence Van Melderen·bioRxiv·Aug 21, 2026
- Long-term evolution of antibiotic persistence in P. aeruginosa lung infections
M. Ghoul, S. B. Andersen, … A. S. Griffin·bioRxiv·Oct 14, 2021
- Antibiotic tolerance, persistence, and resistance of the evolved minimal cell, Mycoplasma mycoides JCVI-Syn3B.
Tahmina Hossain, Heather S. Deter, … Nicholas C. Butzin·iSciencePeer-reviewed·Apr 3, 2021